Total Clarity Wealth Management’s Novavax NVAX Stock Holding History

Total Clarity Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	-$3K	–	725
2022 Q2	$3K	Buy	+50	New	+$2.59K	﹤0.01%	891
2022 Q1	–	Sell	-50	Closed	-$7K	–	668
2021 Q4	$7K	Hold	50	–	–	﹤0.01%	759
2021 Q3	$10K	Buy	+50	New	+$11K	﹤0.01%	678
2021 Q2	–	Sell	-46	Closed	-$8K	–	553
2021 Q1	$8K	Buy	+46	New	+$9.17K	﹤0.01%	602

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Total Clarity Wealth Management's NVAX Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 50 shares — an estimated $3K sold.

Total Clarity Wealth Management first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

Total Clarity Wealth Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 50 Novavax shares in Q3 2022, an estimated $3K.
Total Clarity Wealth Management first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
Total Clarity Wealth Management's Novavax position peaked at $10K in Q3 2021.
253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.